Skip to content

Application of a novel traction device in colonic endoscopic submucosal dissection- a multicenter, prospective, randomized controlled clinical trial

Application of a novel traction device in colonic endoscopic submucosal dissection- a multicenter, prospective, randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090743
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon tumor

Interventions

treatment group:Colonic ESD with the application of traction device
control group:Common ESD

Sponsors

The Second Hospital & Clinical Medical School,Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18-90 years old 2. Early colorectal tumors with a diameter of = 20mm (including lateral spreading tumors and early colorectal cancer); 3. Diagnosed as adenoma or early colorectal tumor (cT1a) through device based image enhanced endoscopy (IEE). If the patient suspected of having cT1b components refuses surgical treatment can also be included; 4. If the reliability of endoscopic diagnosis is high, pathological biopsy results are not necessary;

Exclusion criteria

Exclusion criteria: (1) Patients with severe anemia, coagulation disorders, cardiopulmonary, liver and kidney dysfunction, severe acute infection, and pregnancy; (2) Patients who cannot tolerate intravenous anesthesia; (3) Patients who cannot accept surgery as an alternative; (4) Patients predicted to have deep submucosal invasion by endoscopic ultrasound; (5) Cases with local recurrence after endoscopic resection; (6) Patients who cannot discontinue anticoagulants and anticoagulants (except low-dose aspirin); (7) Other patients for whom ESD is not expected to benefit.

Design outcomes

Primary

MeasureTime frame
Dissection speed;

Secondary

MeasureTime frame
Dissection duration;

Countries

China

Contacts

Public ContactWANG PENGFEI

The Second Hospital & Clinical Medical School, Lanzhou University

wpfw@foxmail.com+86 181 5367 3602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026